register

News & Trends - Pharmaceuticals

Aussie digital health company hits new milestone in AstraZeneca partnership

Health Industry Hub | April 26, 2024 |

Pharma News: Fewer than 50% of asthma patients adhere to their prescribed preventative medications. An Australian digital health company has received US Food and Drug Administration (FDA) approval for its device monitoring technology to enhance outcomes for patients with asthma and chronic obstructive pulmonary disease (COPD).

Adherium’s Hailie Smartinhaler is designed to be compatible with AstraZeneca’s Airsupra (albuterol/budesonide) and Breztri (budesonide/glycopyrrolate/formoterol fumarate) inhaler devices. Airsupra is a rescue medication for asthma patients and Breztri is a triple combination therapy for COPD patients.

AstraZeneca has successfully used the technology in clinical trials and has piloted its use in programs to support patients in the management of their respiratory conditions.  

The Bluetooth-enabled Hailie sensor attaches to the inhaler and is then paired with the Hailie app. The system is designed to help with treatment adherence by tracking medication use and reminding patients if a dose is missed. 

Patients are able to share adherence reports with clinicians by uploading the data to a secure cloud-based portal. This remote patient management platform allows healthcare providers to review the patient’s medication usage and make treatment decisions based on real-time data.

Adherium CEO, Paul Mastoridis, said “Our mission at Adherium has always been to revolutionise the way respiratory conditions are managed. By securing FDA clearance for our Smartinhaler with Airsupra and Breztri, we’re bringing that vision to life, offering patients and healthcare providers a powerful tool in the fight against chronic respiratory diseases.”

Allergist Dr Bill McCann commented on the launch, saying “The combination of the Hailie Smartinhaler with Airsupra and Breztri devices represents a leap forward in our ability to treat and manage asthma and COPD.

“This integration allows for a more nuanced understanding of patient needs and the ability to adjust treatments in real-time, which is invaluable in achieving optimal patient outcomes.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


Human Resources

The return-to-office debate: Where are we in the pendulum's swing?

The return-to-office debate: Where are we in the pendulum’s swing?

Health Industry Hub | May 24, 2024 |

People & Culture: The evolution of hybrid and flexible workplaces has yielded mixed results across the healthcare sector, with some […]

More


News & Trends - MedTech & Diagnostics

Cardinal Health launches local facility for reprocessing of single-use medical devices

Cardinal Health launches local facility for reprocessing of single-use medical devices

Health Industry Hub | May 24, 2024 |

MedTech & Diagnostics News: Cardinal Health is set to launch a cutting-edge facility in Australia dedicated to the reprocessing of […]

More


Medical

New ophthalmic centre to partner on pharma and medtech clinical trials

New ophthalmic centre to partner on pharma and medtech clinical trials

Health Industry Hub | May 24, 2024 |

Medical: The Victorian Deputy Premier and Minister for Medical Research, the Hon Ben Carroll, has launched a cutting-edge ophthalmic clinical […]

More


News & Trends - Pharmaceuticals

Private sector, government and academia gather to tackle barriers in vaccine value chain

Private sector, government and academia gather to tackle barriers in vaccine value chain

Health Industry Hub | May 24, 2024 |

Pharma News: An ‘invite only’ vaccine thought leadership event, aimed at addressing gaps in Australia’s vaccine ecosystem and maximising the […]

More


This content is copyright protected. Please subscribe to gain access.